Advantages of continuous pharmaceutical production

Continuous manufacturing is part of the Industry 4.0 concept and this approach is extended to pharmaceuticals following progress in other industries (moving from "batch manufacturing" to "continuous manufacturing").

Debut Bio has announced its $2.6 million seed funding with KdT Ventures in the lead. The round was oversubscribed and involved Better Ventures, FTW Ventures, and SpringTide Ventures participating.